These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 24217395

  • 1. Is atrial fibrillation always a culprit of stroke in patients with atrial fibrillation plus stroke?
    Kim SJ, Ryoo S, Kwon S, Park YK, Kim JP, Lee GY, Bang OY.
    Cerebrovasc Dis; 2013; 36(5-6):373-82. PubMed ID: 24217395
    [Abstract] [Full Text] [Related]

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 3. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.
    Cerebrovasc Dis; 2013 Dec 10; 36(4):273-80. PubMed ID: 24135809
    [Abstract] [Full Text] [Related]

  • 4. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY.
    Thromb Haemost; 2013 May 10; 109(5):956-60. PubMed ID: 23572113
    [Abstract] [Full Text] [Related]

  • 5. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.
    Circ Arrhythm Electrophysiol; 2013 Oct 10; 6(5):868-74. PubMed ID: 24047706
    [Abstract] [Full Text] [Related]

  • 6. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Takase K, Wakata Y, Nakashima N, Kira J, Murai H.
    J Stroke Cerebrovasc Dis; 2015 Jul 10; 24(7):1629-35. PubMed ID: 25906940
    [Abstract] [Full Text] [Related]

  • 7. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, Savvari P, Manios E, Milionis H, Vemmos K.
    Neurology; 2013 Mar 12; 80(11):1009-17. PubMed ID: 23408865
    [Abstract] [Full Text] [Related]

  • 8. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.
    Thromb Haemost; 2012 Jun 12; 107(6):1172-9. PubMed ID: 22473219
    [Abstract] [Full Text] [Related]

  • 9. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.
    Europace; 2014 Feb 12; 16(2):202-7. PubMed ID: 23813452
    [Abstract] [Full Text] [Related]

  • 10. Adenosine diphosphate-induced platelet aggregation might contribute to poor outcomes in atrial fibrillation-related ischemic stroke.
    Choi JH, Cha JK, Huh JT.
    J Stroke Cerebrovasc Dis; 2014 Mar 12; 23(3):e215-20. PubMed ID: 24274935
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
    Chua SK, Shyu KG, Lu MJ, Lien LM, Lin CH, Chao HH, Lo HM.
    J Thorac Cardiovasc Surg; 2013 Oct 12; 146(4):919-926.e1. PubMed ID: 23628495
    [Abstract] [Full Text] [Related]

  • 12. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E, Wolff A, Lip GY, Lane DA.
    Br J Gen Pract; 2015 Jan 12; 65(630):e16-23. PubMed ID: 25548312
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare].
    Perez-Ortega I, Moniche-Alvarez F, Jimenez-Hernandez MD, Gonzalez-Marcos JR.
    Rev Neurol; 2012 Jul 16; 55(2):74-80. PubMed ID: 22760766
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
    Glotzer TV, Hellkamp AS, Lee KL, Lamas GA.
    Can J Cardiol; 2015 Aug 16; 31(8):1004-11. PubMed ID: 26076964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S, Lane DA, Buller H, Lip GY.
    Thromb Haemost; 2013 Nov 16; 110(5):1074-9. PubMed ID: 24048467
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CHADS2 and CHA2DS2-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation.
    Wu JT, Wang SL, Chu YJ, Long DY, Dong JZ, Fan XW, Yang HT, Duan HY, Yan LJ, Qian P.
    J Atheroscler Thromb; 2017 Feb 01; 24(2):176-184. PubMed ID: 27301462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.